Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal FiO2 Value, Oxygen Reserve Index, and Prevention of Hyperoxemia in Children: A Prospective, Randomized, Single-blind Study

NCT05505032 is registered in ClinicalTrials.gov with Baskent University Ankara Hospital as lead sponsor.

NCT NCT05505032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05505032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal FiO2 Value, Oxygen Reserve Index, and Prevention of Hyperoxemia in Children: A Prospective, Randomized, Single-blind Study
Lead sponsor
Baskent University Ankara Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 17, 2022
Completion date
October 30, 2022
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fraction of inspired oxygen, hyperoxemia, hyperoxia, oxygen reserve index